A new pill, Orforglipron, is set to revolutionize weight loss and diabetes treatment. This daily pill, developed by Eli Lilly ...

A new wave of weight-loss pills, dubbed Ozempic 2.0, promises easier daily dosing, strong results and wider access, with FDA approval expected as early as 2026.

Smart multi-target drugs are redefining how we treat complex diseases by combining AI-driven discovery with mechanistic ...

A conversation with P.E. Moskowitz about the chemical imbalance theory of depression, the false schism between prescription and recreational drugs, and collective psychic pain. P.E. Moskowitz Awoman ...

Eli Lilly’s stock (NYSE: LLY) soared nearly 50%, driven not only by outstanding earnings and a notable margin increase, but ...

Naloxone, also known by the brand name Narcan, is one of the most important drugs in the United States' fight against the opioid crisis. It reverses an opioid overdose nearly instantly, restarting ...

An FDA advisory panel voted in favor of approving the drug in early October. The FDA announced on Friday that it would side with its advisory panel by approving a new opioid drug, called Dsuvia, ...